Literature / General

An important miscue in clopidogrel pharmacogenomics

In the December 28, 2011 issue of the Journal of the American Medical Association, Holmes and colleagues publish what they label as a "systematic review and meta-analysis" of clopidogrel CYP2C19 genotyping, platelet function, and cardiovascular events [1]. There has...

Latest Key Approvals and Alerts in Diabetes & Endocrinology

Latest Key Approvals and Alerts in Diabetes & Endocrinology: June 2-October 24, 2011 On October 19, 2011, the US Food and Drug Administration (FDA) granted expanded approval for the injectable glucagon-like peptide-1 receptor agonist exenatide (Byetta®, Amylin...